Sexual Desire and Pharmacologic Management

Tami S Rowen; James A Simon

doi:10.1016/j.ogc.2024.03.004

Sexual Desire and Pharmacologic Management

Obstet Gynecol Clin North Am. 2024 Jun;51(2):259-271. doi: 10.1016/j.ogc.2024.03.004.

Authors

Tami S Rowen¹, James A Simon²

Affiliations

¹ Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA. Electronic address: Tami.Rowen@ucsf.edu.
² Obstetrics & Gynecology, George Washington University, Washington, DC, USA.

PMID: 38777482
DOI: 10.1016/j.ogc.2024.03.004

Abstract

Female sexual desire is a complex interplay of neurotransmitters and hormones. Diagnosis is based on clinical features and sexual distress. Treatments that affect neurotransmitters and hormones that may be out of balance can help improve sexual desire in women with hypoactive sexual desire disorder.

Keywords: Hormones; Hypoactive sexual desire; Low libido; Neurotransmitters and sexual health.

Publication types

Review

MeSH terms

Female
Humans
Libido* / drug effects
Sexual Dysfunctions, Psychological* / drug therapy